Adagio Medical Holdings, Inc. has announced a significant corporate action: a one-for-thirty reverse stock split of its common stock. This decision, effective November 6, 2026, aims to consolidate shares and potentially enhance the stock's market value. The move comes after stockholder approval at a special meeting held on October 23, 2026.

The reverse stock split means that every thirty shares held by stockholders will be combined into one share. This adjustment will not change the par value of the shares but will affect the number of shares outstanding and the exercise price of stock options. The company is taking this step to improve its stock price and overall market perception, which is crucial for its operations in the competitive surgical and medical instruments industry.

Background

Adagio Medical Holdings, Inc. operates within the surgical and medical instruments and apparatus sector, classified under SIC code 3841. The company is listed on the Nasdaq under the ticker symbol ADGM. The firm has been actively engaging with its stakeholders and has made several recent filings, including a special meeting to discuss the reverse stock split.

What the Filing Says

The recent filing states, "On November 4, 2026, Adagio Medical Holdings, Inc. filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a one-for-thirty (1-for-30) reverse stock split of its outstanding common stock." This amendment will be effective at 5:00 p.m. Eastern Time on November 6, 2026.

Impact

The reverse stock split is expected to affect all stockholders proportionately, with adjustments made to stock options and restricted stock unit awards. No fractional shares will be issued; instead, stockholders entitled to fractional shares will receive a cash payment. This move may influence investor sentiment and the company's market dynamics as it seeks to stabilize its stock price.

What's Next

The company’s common stock will begin trading on The Nasdaq Capital Market on a split-adjusted basis when the market opens on November 9, 2026. This transition will mark a new phase for Adagio Medical Holdings as it implements its strategy to enhance shareholder value.